Announcements Trials
Browse Landscape

Phase

Phase 1 1

Status

Terminated 1

Sponsor Class

INDUSTRY 1

Study Type

Interventional 1

Sponsor

Conditions

Hematologic Neoplasms 8Leukemia 6Infections 5Mycoses 4Leukemia, Myeloid, Acute 4Invasive Fungal Infections 4Myelodysplastic Syndromes 3Multiple Myeloma 3Lymphoma, Follicular 3Wilms Tumor 2Recurrence 2Precursor Cell Lymphoblastic Leukemia-Lymphoma 2Neuroblastoma 2Myeloproliferative Disorders 2Myelodysplastic-Myeloproliferative Diseases 2Lymphoma, T-Cell, Cutaneous 2Lymphoma, Mantle-Cell 2Lymphoma, B-Cell, Marginal Zone 2Lymphoma 2Leukemia, Myeloid, Chronic-Phase 2Leukemia, Myeloid, Chronic, Atypical, BCR-ABL Negative 2Leukemia, Myeloid, Accelerated Phase 2Leukemia, Lymphocytic, Chronic, B-Cell 2Drug-Related Side Effects and Adverse Reactions 2Dendritic Cell Sarcoma, Interdigitating 2Burkitt Lymphoma 2Blast Crisis 2Waldenstrom Macroglobulinemia 1Testicular Neoplasms 1Sezary Syndrome 1

Interventions

Voriconazole 1MSC1992371A 1AZD0466 1

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

1 trials
RecentStart dateEnrollment
Haematological Malignancies × Voriconazole × Clear all
NCT04865419 2025-06-15

Study of AZD0466 Monotherapy or in Combination in Patients With Advanced Haematological Malignancies

AstraZeneca

Phase 1 Terminated
46 enrolled 12 charts

Haematological Malignancies

Data powered by HemOnc (CC BY 4.0) Colophon âš¡